Tardive dystonia: Prevalence, risk factors and clinical features

Neurological Sciences

Volumn 17, Issue 6, 1996, Pages 409-418

  Raja, M ^a   Azzoni, A ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

Prevalence; Risk factors; Tardive dyskinesia; Tardive dystonia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; DYSTONIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; TARDIVE DYSKINESIA;

AGE FACTORS; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; DYSTONIA; FEMALE; HUMANS; MALE; RISK FACTORS; SEX FACTORS;

EID: 0030459055     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. ADITYANJEE, JAYASWAL S.K., CHAN T.M., SUBRAMANIAM M.: ECT for tardive dystonia. Br. J. Psychiatry 156: 433-435, 1990.
2. AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association, 1994.
3. ANDREASEN N.C.: Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1983.
4. ANDREASEN N.C.: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1981.
5. ASNIS G.M., LEOPOLD M.A., DUVOISIN R.C. et al.: A survey of tardive dyskinesia in psychiatric outpatients, Am. J. Psychiatry 134: 1367-1370, 1977.
6. BALDESSARINI R.J.: Chemotherapy in Psychiatry: Principles and Practice. Harvard University Press, Cambridge Mass, 1985.
7. BARNES T.R.E.: A rating scale for drug-induced akathisia. Br. J. Psychiatry 154: 672-676, 1989.
8. BECH P., KASTRUP M., RAFAELSEN O.J.: Minicompendium of rating scales. Acta Psychiatr. Scand. 73 (Suppl. 326), 1986.
9. BLAKE L.M., MARKS R.C., NIERMAN P., LUCHINS D.J.: Clozapine and clonazepam in tardive dystonia. J. Clin. Psychopharmacol. 11: 268-269, 1991.
10. BRANDON S., MCCLELLAND H.A., PROTHEROC C.: A study of facial dyskinesia in a mental hospital population. Br. J. Psychiatry 118: 171-184, 1971.
11. BROWN K.W., WHITE, T.: The psychological consequences of tardive dyskinesia. Br. J. Psychiatry 159: 399-403, 1991.
12. BURKE R.E., FAHN S., JANKOVIC J. et al.: Tardive dystonia: late onset and persistent dystonia caused by antipsychotic drugs. Neurology 32: 1335-1346, 1982.
13. BURKE R.E.: Tardive dyskinesia: current clinical issues. Neurology 34: 1348-1353, 1984.
14. BURKE R.E., RANG U.J.: Tardive dystonia: clinical aspects and treatment. Adv. Neurol. 49: 199-210, 1988.
15. CASEY D.E., TOENNIESSEN L.M.: Neuroleptic treatment in tardive dyskinesia: Can it be developed into a clinical strategy for long-term treatment? In: Bannet J., Belmaker R.H. (Eds.): New Directions in Tardive Dyskinesia Research. Basel: Karger, pp. 65-79, 1983.
16. CASEY D.E., HANSEN T.E.: Spontaneous dyskinesia. In: Jeste D.V., Wyatt R.J. (Eds.). Neuropsychiatric Movement Disorders. Washington, DC, American Psychiatric Press, pp. 68-95, 1984.
17. CASEY D.E.: Tardive dyskinesia, Pathophysiology. In: Bloom F.E., Kupfer D.J. (Eds.). Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp. 1497-1502, 1995.
18. CHIU H., SHUM P., LAU J., LAM L., LEE S.: Prevalence of tardive dyskinesia, tardive dystonia and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong. Am. J. Psychiatry 149: 1081-1085, 1992.
19. COLLERTON D., FAIRBAIRN A., BRITTON P.: Cognitive performance of medicated schizophrenics with tardive dyskinesia. Psychol. Med. 15: 311-315, 1985.
20. EDWARDS H.: The significance of brain damage in persistent oral dyskinesia. Br. J. Psychiatry 116: 271-275, 1970.
21. FAHN S.: Drug treatment of hyperkinetic movement disorders. Semin. Neurol. 7: 192-208, 1987.
22. FAHN S., ELTON R.L. (Members of the UPDRS Development Committee). In: Fahn S., Marsden C.D., Calne D., Goldstein M. (Eds.). Recent Developments in Parkinson's Disease, MacMillan Florham Park, New Jersey, 1987.
23. FAMUYIWA O.O., ECCLESTON D., DONALDSON A.A., GARSIDE R.F.: Tardive dyskinesia and dementia. Br. J. Psychiatry 135: 500-504, 1979.
24. FOLSTEIN M.F., FOLSTEIN S.E., MCHUGH P.: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12: 189-198, 1975.
25. FRIEDMAN J.H., KURASKI L.T., WAGNER R.L: Tardive dystonia in a psychiatric hospital. J. Neurol. Neurosurg. Psychiatry 50: 801-803, 1987.
26. GARDOS G., CASEY D.E.: Tardive dyskinesia and affective disorders. Washington, DC. American Psychiatric Press, 1987.
27. GARDOS G., COLE J.O., SALOMON M., SCHNIEBOLK. S.: Clinical forms of severe tardive dyskinesia. Am. J. Psychiatry 144: 895-902, 1987.
28. GERLACH J., CASEY D.E.: Tardive dyskinesia. Acta Psychiatr. Scand. 77: 369-378, 1988.
29. GIMENEZ-ROLDAN S., MATEO D., BARTOLOME P.: Tardive dystonia and severe tardive dyskinesia. Acta Psychiatr. Scand. 71:: 488-494, 1985.
30. GLAZER W.M., MORGENSTERN H., NIEDZWIECKI, HUGHES J.: Heterogeneity of tardive dyskinesia. Br. J. Psychiatry 152: 253-259, 1988.
31. GRANACHER R.P.: Differential diagnosis of tardive dyskinesia: an overview. Am. J. Psychiatry 138: 1288-1297, 1981.
32. GUREJE O.: Topographic subtypes of tardive dyskineṡia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment and neuropsychological variables. J. Neurol. Neurosurg. Psychiatry 51: 1525-1530, 1988.
33. HYMAN S.E.: Manual of Psychiatric Emergencies. Little, Brown and Company, Boston/Toronto, pp. 259, 1984.
34. JESTE D.V., WYATT R.J.: Understanding and Treating Tardive Dyskinesia. New York, Guilford Press, 1982.
35. KANE J.M., WOERNER M., BORENSTEIN M., WEGNER J., LIEBERMAN J.: Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol. Bull, 22 (1): 254-258, 1986.
36. KANG U.J., BURKE R.E., FAHN S.: Natural history and treatment of tardive dystonia. Mov. Disord. 1: 193-208, 1986.
37. KANG U.J., FAHN S.: Discinesia tardiva. Le basi razionali della terapia, 1: 3-11, 1990.
38. KAPLAN Z., BENJAMIN J. ZOHAR J.: Remission of tardive dystonia with ECT. Convuls. Ther. 7: 280-283, 1991.
39. KEEGAN D.L., RAJPUT A.H.: Drug-induced dystonia tarda - treatment with L-Dopa. Dis. Nerv. Syst. 38: 167-169, 1973.
40. LAMBERTI J.S., BELLNIER T.: Clozapine and tardive dystonia. J. Nerv. Ment. Dis. 181: 137-138, 1993.
41. LIEBERMAN J.A., LESSER M., JOHNS C. et al.: Pharmacologic studies of tardive dyskinesia. J. Clin. Psychopharmacol. 8 (4, suppl.): 575-635, 1988.
42. LIEBERMAN J.A., ALVIR J., MUKERJEE S., KANE J.M.: Treatment of tardive dyskinesia with bromocriptine: a test of the receptor modification strategy. Arch. Gen. Psychiatry 46: 908-913, 1989.
43. LIEBERMAN J.A., SALTZ B.L., JOHNS C.A., et al.: The effects of clozapine on tardive dyskinesia. Br. J. Psychiatry 158: 503-510, 1991.
44. LUCHINS D., GOLDMAN M.: High-dose bromocriptine in a case of tardive dystonia. Biol. Psychiatry 20: 179-181, 1985.
45. MARSALEK M., PAVLAT D.J., PETROVSKY M. et al.: The signs of brain vulnerability in tardive dyskinesia. Schizophr. Res. 1: 231, 1988.
46. MARSDEN C.D., QUINN N.P.: The dystonias. Br. Med. J. 300: 139-144, 1990.
47. MCCLELLAND H.A., METCALFE A.V., KERR T.A. et al.: Facial dyskinesia: a 16-year follow-up study. Br. J. Psychiatry 158: 691-696, 1991.
48. MCGUIRE R., THOMAS P.: Orofacial dyskinesia, cognitive function and medication. Br. J. Psychiatry 149: 216-220, 1986.
49. MEISE U., SCHWITZER J., GUNTHER V. et al.: Tardive dyskinesia and cognitive dysfunction. Schizophr. Res. 1: 232, 1988.
50. MION C.C., ANDREASEN N.C., ARNDT S., SWAYZE V.W. II, COHEN G.A.: MRI abnormalities in tardive dyskinesia. Psychiatry Res. 40: 157-166, 1991.
51. MORGENSTERN H., GLAZER W.M., GIBOWSKI L.D. et al.: Predictors of tardive dyskinesia: results of a cross-sectional study in an out-patient population. J. Chron. Dis. 40: 319-327, 1987.
52. MYSLOBODSKY M.S., TOMER R., HOLDEN T. et al.: Cognitive impairment in patients with tardive dyskinesia. J. Nerv. Ment. Dis. 173: 156-160, 1985.
53. NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH): Psychopharmacology Research Branch: Abnormal Involuntary Movement Scale. Psychopharmacol. Bull. 24: 781-782, 1986.
54. OVERALL J.E., GORHAN D.R.: The Brief Psychiatric Rating Scale. Psychol. Rep., 10: 799-812, 1962.
55. OWENS D.G.C.: Dystonia: A potential psychiatric pitfall Br. J. Psychiatry 156: 620-634, 1990.
56. RAJA M.: Tardive dystonia, Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric impatients. Eur. Arch. Psychiatry Clin. Neurosci. 245: 145-151, 1995.
57. RAJA M., ALTAVISTA M.C., MAISTO G., ALBANESE A.: Tardive lingual dystonia treated with clozapine. Mov. Disord. 11: 585-586, 1996.
58. ROLLER W.C.: Tardive dystonia: diagnosis and treatment. In: Wolf M.E., Mosnaim A.D. (Eds.). Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects. Washington, D.C., American Psychiatric Press, 1988.
59. RUSH M., DIAMOND F., ALPERT M.: Depression as a risk factor in tardive dyskinesia. Biol. Psychiatry 17: 387-392, 1982.
60. SACHDEV P.: The prevalence of tardive dystonia in patients with chronic schizophrenia (letter), Aust NZ J. Psychiatry 25: 446-448, 1991.
61. SALTZ B.L., KANE J.M., WOERNER M.G., et al.: Prospective study of tardive dyskinesia in the elderly. Psychopharmacol. Bull. 25: 52-56, 1989.
62. SCHOOLER N.R., KANE J.M.: Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry 39: 486-487, 1982.
63. SERBY M., GOODGOLD A.: Tardive dyskinesia-like disorder due to basal ganglia infarction (letter). J. Clin. Psychopharmacol. 6: 122, 1986.
64. SIMPSON G.M., LEE J.M., ZOUBOK B., GARDOS G.: A rating scale for tardive dyskinesia. Psychopharmacology (Berlin) 64: 171-179, 1979.
65. SOROKIN J.E., GIORDANI B., MOHS R.C. et al.: Memory impairment in schizophrenic patients with tardive dyskinesia. Biol. Psychiatry 23: 129-135, 1988.
66. STRUVE F.A., WILLNER A.E.: Cognitive dysfunction and tardive dyskinesia. Br. J. Psychiatry 143: 597-600, 1983.
67. VAN PUTTEN T., WIRSHING W., MARDER S.: Tardive Meige syndrome responsive to clozapine. J. Clin. Psychopharmacol. 10: 381-382, 1990.
68. VOJCIK J.D., FALK W.E., FINK J.S., COLE J.O., GELEN-BERG A.J.: A review of 32 cases of tardive dystonia. Am. J. Psychiatry 148: 1055-1059, 1991.
69. WADDINGTON J.L., YOUSSEF H.A.: An unusual cluster of tardive dyskinesia in schizophrenia: Association with cognitive dysfunction and negative symptoms. Am. J. Psychiatry 143: 1162-1165, 1986.
70. WADDINGTON J.L., YOUSSEF H.A., DOLPHIM C., KINSELLA A.: Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Arch. Gen. Psychiatry. 44: 907-912, 1987.
71. WADE J.B., TAYLOR M.A., KASPRISIN A. et al.: Tardive dyskinesia and cognitive impairment. Biol. Psychiatry 22: 393-395, 1987.
72. WEGNER J.T., CATALANO F., GIBRALTER J. et al.: Schizophrenics with tardive dyskinesia: neuropsychological deficit and family psychopathology. Arch. Gen. Psychiatry 42: 860-865, 1985.
73. YASSA R., NAIR N.P.V., DIMITRY R.: Prevalence of tardive dystonia, Acta Psychiatr. Scand. 73: 629-633, 1986.
74. YASSA R., NAIR V., ISKANDAR H.: A comparison of severe tardive dystonia and severe tardive dyskinesia. Acta Psychiatr. Scand. 80: 155-159, 1989.
75. YASSA R., NAIR N.P.V., ISKANDAR H., SCHWARTZ G.: Factors in the development of severe forms of tardive dyskinesia. Am. J. Psychiatry 147: 1156-1163, 1990.
76. YASSA R., JESTE D.V.: Gender differences in tardive dyskinesia: A critical review of the literature. Schizophr. Bull. 18: 701-715, 1992.